Socializing a Science-Based Digital Therapeutic for Substance Use Disorders
Launched by SQUARE2 SYSTEMS, INC. · Dec 5, 2022
Trial Information
Current as of January 21, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a smartphone app called Laddr®, which is designed to help people who are trying to overcome substance use disorders. The goal is to see if using this app, along with regular treatment, can improve outcomes for individuals undergoing outpatient treatment. A unique feature of this version of the app is that it allows participants to include a support person, like a friend or family member, in their journey to recovery, which may make the process more effective and supportive.
To be eligible for this study, participants must be 18 years or older, in the first 30 days of a new outpatient treatment at the Farnum Center, and have access to a working smartphone. They also need to be able to identify someone who can support them in the study. Participants will be asked to use the app and attend their regular treatment sessions for the entire duration of the study. This research is currently recruiting individuals, and it’s a great opportunity for those who are looking for additional resources to aid their recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • In first 30 days of new outpatient treatment episode at the Farnum Center
- • 18 years of age or older
- • Ability to provide informed consent
- • Has access to a functioning smartphone
- • Able to identify a support person who can participate in the study with them
- • Available to participate for the full duration of the study.
- Exclusion Criteria:
- • Inability to understand or read English.
About Square2 Systems, Inc.
Square2 Systems, Inc. is a pioneering clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. With a focus on enhancing patient outcomes and streamlining the clinical trial process, the company leverages cutting-edge technology and a collaborative approach to drive efficiency and data integrity. Square2 Systems, Inc. is committed to fostering partnerships with healthcare professionals and institutions to ensure that groundbreaking therapies reach patients in a timely manner, while adhering to the highest ethical and regulatory standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, New Hampshire, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials